{"id":616172,"title":"Qualifying notice for Lyvdelzi (294551) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-02","captureTimestamp":"2026-03-02T17:49:16.052000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-lyvdelzi-294551.html","snippet":"Qualifying notice for Lyvdelzi (294551) Pharmaceutical Drugs Directorate Holland Cross, Tower \"B\" 6th Floor, 1600 Scott Street Address Locator #3106B Ottawa ON K1A 0K9 Dossier ID: e288949 Control number: 294551 Gilead Sciences Canada Inc. c/o [name of employee removed] [employee…","rawSnapshotUrl":"/api/snapshots/raw/616172","browseUrl":"https://replay.healtharchive.ca/job-6/20260302174916/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/notice-compliance/conditions/qualifying-notice-lyvdelzi-294551.html#ha_snapshot=616172","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}